Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1996
10/08/1996US5563162 Bradykinin antagonist quinolines
10/08/1996US5563160 N-cyano-N'-pyridylguanidines as serotonin antagonists
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563125 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pharmaceutical compositions
10/08/1996US5563120 Cytokine preparation for immunotherapy
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
10/08/1996US5562902 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
10/08/1996US5562900 Aspergillus fermentation extract
10/06/1996CA2173047A1 Retinoid-like heterocycles
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030513A1 Apoptosis regulating gene
10/03/1996WO1996030505A1 Methods for screening compounds for estrogenic activity
10/03/1996WO1996030397A1 New peptides with immunomodulatory effects
10/03/1996WO1996030365A1 Radiosensitizing diamines and their pharmaceutical preparations
10/03/1996WO1996030363A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030362A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030356A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/03/1996WO1996030355A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/03/1996WO1996030347A1 Quinazoline derivatives
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/03/1996WO1996030056A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996WO1996030055A2 Radiolabeled peptides for diagnosis and therapy
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030018A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030017A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/03/1996WO1996030015A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030014A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030007A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
10/03/1996WO1996030003A1 Medicaments for the selective treatment of tumour tissues
10/03/1996WO1996023489A3 Use of carotinoids for preparing medicaments for treating dermatoses
10/03/1996WO1996013498A3 L-erythrosyl nucleosides
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216564A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216526A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216381A1 Radiosensitizing diamines and their pharmaceutical preparations
10/03/1996CA2215833A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996CA2191214A1 Apoptosis regulating gene
10/03/1996CA2189656A1 New peptides with immunomodulatory effects
10/02/1996EP0735046A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient
10/02/1996EP0735045A1 Process for the preparation of 2,2'-andhydro- and 2'-keto-1-(3',5'-di-o-protected-beta -d-arabinofuranosyl) nucleosides
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996DE19513040A1 Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneo Lester, processes for their preparation and their pharmaceutical use
10/02/1996CN1132511A Matrix metalloprotease inhibitors
10/02/1996CN1132506A New Bis-naphthalimides for the treatment of cancer
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/01/1996US5561148 Oxazolidine derivative
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561141 MDR reversal agents
10/01/1996US5561133 Thymidylate synthase inhibiting quinazolinones
10/01/1996US5561126 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents
10/01/1996US5561125 Antitumor agents
10/01/1996US5561123 Antitumor agents, anticarcinogenic agent
10/01/1996US5561121 Antitumor alkylating agent
10/01/1996US5561119 Glycosylated prodrugs, their method of preparation and their uses
10/01/1996US5561050 Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
10/01/1996US5561043 Genetic engineering
10/01/1996CA1338627C Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
10/01/1996CA1338619C Lectin complex and method and probe for making same
09/1996
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029394A1 Method for treating tumors
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029336A1 Chemical compounds
09/26/1996WO1996029327A1 Trypsin and thrombin inhibitors
09/26/1996WO1996029321A1 10-DEACETYLBACCATINE III AND 10-DEACETYL 14β-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029068A2 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2215162A1 Vectors for gene delivery
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996CA2214107A1 Fucopeptides
09/26/1996CA2211448A1 Rage tumor rejection antigens
09/25/1996EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells
09/25/1996EP0733372A2 Pharmaceutical base for the formulation of nanosuspensions
09/25/1996EP0733365A2 Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
09/25/1996EP0733358A2 Nanosuspensions for intravenous application
09/25/1996EP0733110A1 Tuberous sclerosis 2 gene and uses thereof
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733066A1 Pretargeting methods and compounds
1 ... 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 ... 2211